D De Ruysscher
Treatment of brain metastases in small cell lung cancer: Decision-making amongst a multidisciplinary panel of European experts
Putora P, Pöttgen C, Reck M, Blackhall F, Cappuzzo F, Besse B, Novello S, Garrido P, Felip E, O'Brien M, Paz Ares L, de Marinis F, Westeel V, Widder J, Peeters S, Troost E, Fischer G, Früh M, Califano R, Faivre-Finn C, Van Houtte P, McDonald F, Nestle U, Dziadziuszko R, Le Péchoux C, Ramella S, Belderbos J, Slotman B, De Ruysscher D. Treatment of brain metastases in small cell lung cancer: Decision-making amongst a multidisciplinary panel of European experts. Radiother Oncol 2020; 149:84-88.
20.04.2020Treatment of brain metastases in small cell lung cancer: Decision-making amongst a multidisciplinary panel of European experts
20.04.2020Radiother Oncol 2020; 149:84-88
Putora Paul Martin, Pöttgen C, Reck M, Blackhall F, Cappuzzo F, Besse B, Novello S, Garrido P, Felip E, O'Brien M, Paz Ares L, de Marinis F, Westeel V, Widder J, Peeters S, Troost E G C, Fischer G F, Früh Martin, Califano R, Faivre-Finn C, Van Houtte P, McDonald F, Nestle U, Dziadziuszko R, Le Péchoux C, Ramella S, Belderbos J, Slotman B J, De Ruysscher D
Choice of second-line systemic therapy in stage IV small cell lung cancer (SCLC) - A decision-making analysis amongst European lung cancer experts
Früh M, De Ruysscher D, Westeel V, de Marinis F, Paz Ares L, O'Brien M, Felip E, Garrido P, Novello S, Besse B, Cappuzzo F, Califano R, Blackhall F, Reck M, Panje C, Putora P. Choice of second-line systemic therapy in stage IV small cell lung cancer (SCLC) - A decision-making analysis amongst European lung cancer experts. Lung Cancer 2020; 146:6-11.
30.03.2020Choice of second-line systemic therapy in stage IV small cell lung cancer (SCLC) - A decision-making analysis amongst European lung cancer experts
30.03.2020Lung Cancer 2020; 146:6-11
Früh Martin, De Ruysscher D, Westeel V, de Marinis F, Paz Ares L, O'Brien M, Felip E, Garrido P, Novello S, Besse B, Cappuzzo F, Califano R, Blackhall F, Reck M, Panje C M, Putora Paul Martin
ERS Statement on harmonised standards for lung cancer registration and lung cancer services in Europe
Rich A, McPhelim J, Meert A, Milroy R, Mutti L, Paesmans M, Peake M, Putora P, De Ruysscher D, Sculier J, Schepereel A, Subotic D, Van Schil P, Massard G, Konsoulova A, Baldwin D, Beckett P, Berghmans T, Boyd J, Faivre-Finn C, Galateau-Salle F, Gamarra F, Grigoriu B, Hansen N, Hardavella G, Jakobsen E, Jovanovic D, Blum T. ERS Statement on harmonised standards for lung cancer registration and lung cancer services in Europe. Eur Respir J. 2018
25.10.2018ERS Statement on harmonised standards for lung cancer registration and lung cancer services in Europe
25.10.2018Eur Respir J. 2018
Rich A L, McPhelim J, Meert A P, Milroy R, Mutti L, Paesmans M, Peake M D, Putora Paul Martin, De Ruysscher D, Sculier J P, Schepereel A, Subotic D, Van Schil P, Massard G, Konsoulova A, Baldwin D R, Beckett P, Berghmans T, Boyd J, Faivre-Finn C, Galateau-Salle F, Gamarra F, Grigoriu B, Hansen N C, Hardavella G, Jakobsen E, Jovanovic D, Blum T G
Small-cell lung cancer (SCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Früh M, De Ruysscher D, Popat S, Crinò L, Peters S, Felip E, ESMO Guidelines Working Group. Small-cell lung cancer (SCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2013; 24 Suppl 6:vi99-105.
27.06.2013Small-cell lung cancer (SCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
27.06.2013Ann Oncol 2013; 24 Suppl 6:vi99-105
Früh M, De Ruysscher D, Popat S, Crinò L, Peters S, Felip E, ESMO Guidelines Working Group